The schematic diagram of the molecular mechanism (Fig. 6J) shows that, when S1PR1 is activated by S1P or a related agonist in ovarian cancer cells, PDK1 expression is increased, LATS1/2 expression is inhibited, and YAP expression is increased, thereby inhibiting ovarian cancer cell senescence. Here, S1PR1 is linked to ovarian cancer.